Receiveable Turnover: An accounting measure used to quantify a firm's effectiveness in extending credit as well as collecting debts. Calculated as: Total Revenues / Accounts Receivable
Vitro Diagnostics (VODG) had Receiveable Turnover of 9.00 for the most recently reported fiscal year, ending 2024-10-31.
| Income Statement Financials | |
$1.86M |
|
$-9.87M |
|
$0.43M |
|
$1.43M |
|
$11.01M |
|
$-9.15M |
|
$-0.72M |
|
$-9.87M |
|
$-9.87M |
|
$-9.87M |
|
$-9.87M |
|
$-9.87M |
|
$-9.87M |
|
$-9.15M |
|
$-4.83M |
|
4.46M |
|
4.46M |
|
$-2.21 |
|
$-2.21 |
|
| Balance Sheet Financials | |
$0.98M |
|
$0.14M |
|
$4.11M |
|
$5.09M |
|
$10.06M |
|
$3.05M |
|
$4.03M |
|
$14.09M |
|
$-9.00M |
|
$-12.62M |
|
$-9.00M |
|
4.46M |
|
| Cash Flow Statement Financials | |
$-3.24M |
|
$-0.01M |
|
$3.71M |
|
$0.10M |
|
$0.57M |
|
$0.47M |
|
$1.96M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
0.10 |
|
-- |
|
-- |
|
-0.51 |
|
-0.92 |
|
77.03% |
|
-493.25% |
|
-493.25% |
|
-260.08% |
|
-532.08% |
|
-532.08% |
|
$-3.24M |
|
-- |
|
-- |
|
-- |
|
0.36 |
|
3.69 |
|
|
Receiveable Turnover |
9.00 |
40.58 |
|
109.69% |
|
78.24% |
|
-194.02% |
|
166.05% |
|
$-2.02 |
|
$-0.73 |
|
$-0.73 |
|